Inventor · disambiguated record
Harun Takruri
Also filed as: CHAVERS JANE E · TAKRURI HARUN
13 granted patents·32 pending applications·317 citations·filing 1978–2025
93Inventor score
Files withSYDNEXIS INC14NEWPORT RES INC13FRIEDLAENDER MITCHELL H4INOTEK PHARMACEUTICALS CORP4ALLERGAN PHARMA1
Top patents by PatentIndex Score
45 records- 0198US10953002B2Ophthalmic compositionSYDNEXIS INC·Filed 2020·Granted Mar 23, 2021·11 cites·15 claims
- 0298US10940145B2Ophthalmic compositionSYDNEXIS INC·Filed 2020·Granted Mar 9, 2021·19 cites·23 claims
- 0398US10888557B2Ophthalmic compositionSYDNEXIS INC·Filed 2020·Granted Jan 12, 2021·20 cites·23 claims
- 0498US10813923B1Ophthalmic compositionSYDNEXIS INC·Filed 2020·Granted Oct 27, 2020·11 cites·15 claims
- 0597US10842787B2Ophthalmic compositionSYDNEXIS INC·Filed 2016·Granted Nov 24, 2020·15 cites·19 claims
- 0695US11382909B2Ophthalmic compositionSYDNEXIS INC·Filed 2019·Granted Jul 12, 2022·4 cites·25 claims
- 0793US5272135AMethod for the stabilization of methionine-containing polypeptidesCHIRON OPHTHALMICS INC·Filed 1991·Granted Dec 21, 1993·142 cites·25 claims
- 0891US2024398705A1Ophthalmic compositionSYDNEXIS INC·Filed 2024·Application pending·0 cites
- 0989US11090356B2Aqueous suspensions of cyclosporinNEWPORT RES INC·Filed 2021·Granted Aug 17, 2021·2 cites·21 claims
- 1087US4210633AFlurandrenolide film formulationLILLY CO ELI·Filed 1978·Granted Jul 1, 1980·62 cites·2 claims
- 1185US11324800B2Aqueous suspensions of cyclosporinNEWPORT RES INC·Filed 2021·Granted May 10, 2022·1 cites·11 claims
- 1285US2022409604A1Ophthalmic compositionSYDNEXIS INC·Filed 2022·Application pending·0 cites
- 1385US2022409603A1Ophthalmic compositionSYDNEXIS INC·Filed 2022·Application pending·0 cites
- 1485US2022409605A1Ophthalmic compositionSYDNEXIS INC·Filed 2022·Application pending·0 cites
- 1585US2025255810A1Ophthalmic compositionSYDNEXIS INC·Filed 2025·Application pending·0 cites
- 1683US9522160B2Ophthalmic formulationsINOTEK PHARMACEUTICALS CORP·Filed 2014·Granted Dec 20, 2016·2 cites·13 claims
- 1783US2022265632A1Ophthalmic compositionSYDNEXIS INC·Filed 2022·Application pending·0 cites
- 1883US2022265631A1Ophthalmic compositionSYDNEXIS INC·Filed 2022·Application pending·0 cites
- 1982US2022378775A1Ophthalmic compositionSYDNEXIS INC·Filed 2022·Application pending·0 cites
- 2073US2021145925A1Method of treating ophthalmic conditionsNEWPORT RES INC·Filed 2021·Application pending·0 cites
- 2173US2021138026A1Method of treating ophthalmic conditionsNEWPORT RES INC·Filed 2021·Application pending·0 cites
- 2273US2021187060A1Method of treating ophthalmic conditionsNEWPORT RES INC·Filed 2021·Application pending·0 cites
- 2373US2021145926A1Oil-free and fat-free aqueous suspensions of cyclosporinNEWPORT RES INC·Filed 2021·Application pending·0 cites
- 2473US2021177934A1Method of treating ophthalmic conditionsNEWPORT RES INC·Filed 2021·Application pending·0 cites
- 2573US2021177933A1Method of treating ophthalmic conditionsNEWPORT RES INC·Filed 2021·Application pending·0 cites
- 2673US2021145927A1Oil-free and fat-free aqueous suspensions of cyclosporinNEWPORT RES INC·Filed 2021·Application pending·0 cites
- 2773US2021177935A1Method of treating ophthalmic conditionsNEWPORT RES INC·Filed 2021·Application pending·0 cites
- 2871US2020376075A1Oil-free and fat-free aqueous suspensions of cyclosporinNEWPORT RES INC·Filed 2020·Application pending·0 cites
- 2969US4743588ACompositions and methods of enhancing transdermal and transmembrane penetration systemic agentsALLERGAN PHARMA·Filed 1984·Granted May 10, 1988·28 cites·12 claims
- 3067US2022233636A1Aqueous suspensions of cyclosporinWELLSPRING OPHTHALMICS INC·Filed 2022·Application pending·0 cites
- 3161US2015352176A1Oil-free and fat-free aqueous suspensions of cyclosporinNEWPORT RES INC·Filed 2015·Application pending·0 cites
- 3260US2017049799A1Ophthalmic formulationsINOTEK PHARMACEUTICALS CORP·Filed 2016·Application pending·0 cites
- 3355US2020237859A1Aqueous suspensions of cyclosporinNEWPORT RES INC·Filed 2020·Application pending·0 cites
- 3454US7887859B2Methods of treating epiphoraRIOLAN TECHNOLOGIES INC·Filed 2007·Granted Feb 15, 2011·0 cites·21 claims
- 3551US2006188576A1Pirenzepine ophthalmic gelTAKRURI HARUN·Filed 2006·Application pending·0 cites
- 3651US2017151273A1Ophthalmic formulationsINOTEK PHARMACEUTICALS CORP·Filed 2016·Application pending·0 cites
- 3750US2004137069A1Pirenzepine ophthalmic gelFiled 2003·Application pending·0 cites
- 3847US2012028910A1Storage-stable aqueous ophthalmic formulationsCOMBAL JEAN-PHILIPPE·Filed 2008·Application pending·0 cites
- 3945US2007167526A1Topical mecamylamine formulations for ocular administration and uses thereofZHANG XIAOMING·Filed 2006·Application pending·0 cites
- 4043US2007166402A1Compositions, methods and kits for removing debris from an ocular areaFRIEDLAENDER MITCHELL H·Filed 2006·Application pending·0 cites
- 4137US2018250313A1Compounds and formulations for treating ophthalmic diseasesVIEWPOINT THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4234US2008015250A1Ultraviolet absorbing ophthalmic compositionsFRIEDLAENDER MITCHELL H·Filed 2007·Application pending·0 cites
- 4334US2007259021A1Compositions, Methods, and Kits for Treating Dry EyeFRIEDLAENDER MITCHELL H·Filed 2007·Application pending·0 cites
- 4433US2011097425A1Methods of Treating EpiphoraFRIEDLAENDER MITCHELL H·Filed 2011·Application pending·0 cites
- 4532US2011123622A1Ophthalmic formulation and method of manufacture thereofINOTEK PHARMACEUTICALS CORP·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Harun Takruri files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →